December 05, 2012
Walgreen Co. asked an Illinois federal court on Tuesday to dismiss a putative class action accusing it of falsely marketing its glucosamine chondroitin complex joint health products, saying the plaintiff relies on studies related to a disease the products were never intended to treat.